Clinical Trials During the COVID-19 Pandemic

Back in March 2020, at the beginning of the intense lock down due to the coronavirus pandemic, the FDA published a guidance on the considerations for the conduct of clinical trials during the public health emergency.  In addition to some general information, the guidance includes some Q&A at the end on some important questions regarding the conduct of clinical trials during the pandemic.  This guidance has been updated several time since the original publication with additional Q&As added (www.fda.gov/media/136238/download).  The most recent updated is now dated June 3, 2020.  If you are involved  in the conduct of clinical trials and have questions on how to proceed during this time, consult the document for helpful information.

Advertisement